Saturday links: restraining the chaos
Tadas Viskanta
Abnormal Returns
2 days ago
3 MIN READ
Robotaxis
- 2026 is going to be the year of the robotaxi. (unchartedterritories.tomaspueyo.com)
- Self-driving cars still face a lot of edge cases. (strangecosmos.substack.com)
Autos
- BYD outsold Tesla ($TSLA) in 2025. (sherwood.news)
- Hybrids should continue to take market share in 2026. (news.dealershipguy.com)
- Uber ($UBER) has been slow to remove drivers accused of sexual assault from the platform. (nytimes.com)
- States are finally beginning to crackdown on aggressive driving. (indianacapitalchronicle.com)
Energy
- Electricity prices in the U.S. are only going in one direction. (wsj.com)
- Cheap solar is rolling out across Africa. (nytimes.com)
- Britain’s electricity grid needs an overhaul. (wsj.com)
Environment
- Iceland hit 68°F on Christmas Eve. (semafor.com)
- We are still underestimating the risks of wildfire smoke. (grist.org)
- Cutting food waste is an environment win-win-win. (goodgoodgood.co)
- The Univ. of Nebraska is eliminating it Earth and Atmospheric Sciences Department. (grist.org)
Animals
- Eight new findings including ‘Greenland sharks defy aging, living as long as 400 years.’ (smithsonianmag.com)
- Meet five new species discovered in 2025 including the bumpy snailfish. (npr.org)
AI
- The Association of Chartered Certified Accountants is moving exams in-person due to remote (AI) cheating. (semafor.com)
- Using AI requires having to fact check it. (wsj.com)
- AI is taking the fun out of games. (bloomberg.com)
- AI is an assistant, not an oracle. (mutualfundobserver.com)
Infectious disease
- Influenza cases in the U.S. are soaring. (wsj.com)
- U.S. measles cases topped 2,000 in 2025. (abcnews.go.com)
- Bacterial vaginosis is not just an issue for women. (nytimes.com)
- The CDC not only permits a second Covid dose for those over 65, or immunocompromised, but recommends it. (washingtonpost.com)
Medicine
- 10 breakthroughs in medicine in 2025 including a new treatment for malaria. (breakingground.substack.com)
- Some medical breakthroughs in 2025 including a new antibody treatment for multiple myeloma. (scientificdiscovery.dev)
Health
- Why aren’t sickle cell patients getting life changing treatments? (politico.com)
- Why the ovaries have been overlooked from a health perspective. (msn.com)
- Why the NIH renewed a slew of paused grants. (statnews.com)
- How much of the fall in murder rates is due to better treatment? (pmc.ncbi.nlm.nih.gov)
Pasta
- Lovers of Italian-made pasta are catching a tariff break. (axios.com)
- How Kraft Mac and Cheese lost its lead. (wsj.com)
Food
- How much does a steakhouse net on a $500 bill? (wsj.com)
- The UK has banned the boiling of live lobsters. (semafor.com)
- The financial downside of introducing your children to sushi. (wsj.com)
Entertainment
- The ‘Stranger Things’ finale performed well in the theater. (spyglass.org)
- ‘Zootopia 2’ is Disney’s ($DIS) highest grossing animated film. (variety.com)
- What’s the future for Mubi? (vulture.com)
Sports
- How the Pac 12 came back from the dead. (frontofficesports.com)
- F.C. Barcelona is uniquely loaded down with debt. (nytimes.com)
- Warren Buffett’s March Madness contest will continue. (frontofficesports.com)
Children
- Why don’t all schools ban cellphones is the classroom? (wsj.com)
- Children in youth sports are burning out earlier and faster. (nytimes.com)
Earlier on Abnormal Returns
- What you missed in our Friday linkfest. (abnormalreturns.com)
- Podcast links: the sounds of silence. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
- Some things that went right in 2025 including ‘Cell phone bans expand in schools worldwide.’ (mutualfundobserver.com)
- 25 good things that happened in 2025 including ‘No hurricanes made landfall in the United States for the first time in a decade.’ (wapo.st)
- 97 ways the world got better in 2025 including ‘Once-dilapidated Route 66 motels are being transformed into affordable housing.’ (reasonstobecheerful.world)
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.
